Wenying Shan
University of Macau(MO)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, ATP Synthase and ATPases Research, Biochemical and Molecular Research, Computational Drug Discovery Methods, Mitochondrial Function and Pathology
Most-Cited Works
- → The development of small-molecule inhibitors targeting hexokinase 2(2022)59 cited
- → Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing(2023)34 cited
- → Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis(2023)26 cited
- → Convolutional Neural Network-based Virtual Screening(2020)15 cited
- → Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models(2023)14 cited
- → Repurposing the Hedgehog pathway inhibitor, BMS-833923, as a phosphatidylglycerol-selective membrane-disruptive colistin adjuvant against ESKAPE pathogens(2023)13 cited
- → GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47(2023)7 cited
- → Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models(2024)3 cited
- → Combined inhibition of hexokinase 2 and pyruvate dehydrogenase surmounts SHP2 inhibitor resistance in non-small cell lung cancer with hybrid metabolic state harboring KRAS Q61H mutation(2025)2 cited
- → Benserazide‑mediated targeting hexokinase 2 enhances the cytotoxicity of cisplatin in non-small cell lung cancer cell models(2025)1 cited